Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership212,074 shares
Latest Disclosed Value $ 8,548,702
Ameriprise Financial Inc ownership in HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Ameriprise Financial Inc filed a 13F-HR form disclosing ownership of 212,074 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $7,314,432 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 411,170 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -48.42% during the quarter. The current value of the position is $13,411,560 USD.

Ameriprise Financial Inc has a history of taking positions in derivatives of the underlying security (HTD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HTD / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 212,074 -199,096 -48.42 8,549 -40.26 0.0004
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 411,170 188,794 84.90 14,309 -22.58 0.0032
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 222,376 -196,807 -46.95 18,482 -39.93 0.0042
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 419,183 154,602 58.43 30,768 -11.63 0.0076
2025-05-14 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 264,581 -52,737 -16.62 34,818 117.76 0.0094
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 317,318 -74,955 -19.11 15,990 -11.93 0.0041
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 392,273 39,152 11.09 18,154 57.92 0.0047
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 353,121 60,221 20.56 11,496 55.75 0.0031
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 292,900 18,060 6.57 7,382 -17.31 0.0020
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 274,840 -21,461 -7.24 8,927 10.57 0.0027
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 296,301 -26,110 -8.10 8,074 12.55 0.0027
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 322,411 -40,367 -11.13 7,174 -8.71 0.0022
2023-05-22 2023-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 362,778 -10,910 -2.92 7,858 3.52 0.0026
2023-05-15 2023-03-31 13F COPART COM 218352102 362,778 -10,910 7,858 0.0005
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 373,688 -13,109 -3.39 7,590 -23.47 0.0026
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 386,797 -10,529 -2.65 9,918 4.96 0.0037
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 397,326 -3,574 -0.89 9,449 4.66 0.0033
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 400,900 -1,558 -0.39 9,028 13.27 0.0027
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 402,458 -37,141 -8.45 7,970 -7.87 0.0022
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 439,599 -20,473 -4.45 8,651 -14.52 0.0028
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 460,072 -10,483 -2.23 10,121 -9.59 0.0031
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 470,555 24,585 5.51 11,194 -4.05 0.0037
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 445,970 -15,644 -3.39 11,667 45.20 0.0041
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 461,614 -21,372 -4.42 8,035 -1.10 0.0033
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 482,986 -18,153 -3.62 8,124 36.35 0.0035
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 501,139 -26,450 -5.01 5,958 -6.67 0.0031
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 527,589 -15,686 -2.89 6,384 -16.85 0.0027
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 543,275 -57,240 -9.53 7,678 14.67 0.0034
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 600,515 -15,601 -2.53 6,696 -7.44 0.0030
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 616,116 -13,011 -2.07 7,234 -13.93 0.0033
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 629,127 -2,815 -0.45 8,405 -5.12 0.0042
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 631,942 67,706 12.00 8,859 -0.12 0.0031
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 564,236 -286,267 -33.66 8,870 -36.59 0.0039
2018-05-14 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 850,503 -1,565 -0.18 13,989 -9.09 0.0063
2018-02-12 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 852,068 550,373 182.43 15,388 164.31 0.0070
2017-11-07 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 301,695 301,695 5,822 0.0028
2017-05-05 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -116,360 -100.00 0 -100.00
2017-02-03 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 116,360 113,042 3,406.93 844 16,780.00 0.0005
2013-11-14 2013-09-30 13F CORCEPT THERAPEUTICS COM 218352102 3,318 0 0.00 5 -16.67 0.0000
2013-08-14 2013-06-30 13F CORCEPT THERAPEUTICS COM 218352102 3,318 3,318 6 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS OPT Put 23,700 -79.67 825 -91.50 n/a n/a n/a
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS OPT Put 116,600 9,691 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.